4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
4.640
-0.030 (-0.64%)
At close: Feb 21, 2025, 4:00 PM
4.870
+0.230 (4.96%)
After-hours: Feb 21, 2025, 5:44 PM EST
4D Molecular Therapeutics Stock Forecast
FDMT's stock price has decreased by -83.06% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for 4D Molecular Therapeutics stock have an average target of 36.33, with a low estimate of 6.00 and a high estimate of 58. The average target predicts an increase of 682.97% from the current stock price of 4.64.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for 4D Molecular Therapeutics stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 → $30 | Strong Buy | Maintains | $39 → $30 | +546.55% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +675.86% | Feb 10, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $8 → $6 | Sell | Maintains | $8 → $6 | +29.31% | Jan 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $31 → $27 | Buy | Maintains | $31 → $27 | +481.90% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +675.86% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
1.53M
from 20.72M
Decreased by -92.63%
Revenue Next Year
3.96M
from 1.53M
Increased by 159.36%
EPS This Year
-2.98
from -2.58
EPS Next Year
-3.67
from -2.98
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 5.8M | 17.7M | 18.9M | |||
| Avg | 1.5M | 4.0M | 5.5M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -72.1% | 1,061.3% | 376.9% | |||
| Avg | -92.6% | 159.4% | 38.5% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.78 | -3.21 | -3.10 | |||
| Avg | -2.98 | -3.67 | -4.01 | |||
| Low | -3.21 | -4.15 | -5.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.